Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Vulvar Neoplasms × Drug Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 70 Breast Neoplasms 30 Rectal Neoplasms 21 Colorectal Neoplasms 20 Lung Neoplasms 19 Neoplasms 18 Esophageal Squamous Cell Carcinoma 18 Neoplasm Metastasis 15 Head and Neck Neoplasms 15 Esophageal Neoplasms 15 Stomach Neoplasms 12 Squamous Cell Carcinoma of Head and Neck 12 Pancreatic Neoplasms 12 Triple Negative Breast Neoplasms 11 Ovarian Neoplasms 11 Small Cell Lung Carcinoma 10 Carcinoma, Squamous Cell 10 Nasopharyngeal Carcinoma 9 Colonic Neoplasms 8 Recurrence 7 Prostatic Neoplasms 7 Lymphoma 7 Leukemia, Myeloid, Acute 7 Sarcoma 6 Lymphoma, Non-Hodgkin 6 Lymphoma, Large B-Cell, Diffuse 6 Uterine Cervical Neoplasms 5 Fallopian Tube Neoplasms 5 Cholangiocarcinoma 5 Carcinoma, Ovarian Epithelial 5

Interventions

pembrolizumab 5 Cisplatin 4 Radiotherapy 3 Nivolumab 3 lenvatinib 2 Specimen Handling 2 Platinum 2 Papillomavirus Vaccines 2 Paclitaxel 2 Ipilimumab 2 Gemcitabine 2 Carboplatin 2 CTLA-4 Antigen 2 Bleomycin 2 Bevacizumab 2 1,2-diaminocyclohexaneplatinum II citrate 2 zimberelimab 1 liposomal doxorubicin 1 dostarlimab 1 cemiplimab 1 belzutifan 1 antineoplaston AS 2-1 1 antineoplaston A10 1 alovudine 1 Watchful Waiting 1 Vorinostat 1 Vaccines, Synthetic 1 Vaccines 1 Ritonavir 1 Radiotherapy, Intensity-Modulated 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05076942 2023-08-01

GROINSS-VIII

University Medical Center Groningen

Phase 2 Recruiting

Lymphatic Metastasis, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡